Filing Details
- Accession Number:
- 0001447028-21-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 17:06:23
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2021-02-10 17:06:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447028 | Arbutus Biopharma Corp | ABUS | Pharmaceutical Preparations (2834) | 980597776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635326 | J. Michael Mcelhaugh | C/O Arbutus Biopharma Corporation 701 Veterans Circle Warminster PA 18974 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-09 | 20,000 | $5.00 | 1,307,457 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.
Billionaire Hedge Funds
